Cellectis SA (STU:ZVAA)
€ 1.48 -0.03 (-1.99%) Market Cap: 148.13 Mil Enterprise Value: -4.47 Mil PE Ratio: 0 PB Ratio: 1.47 GF Score: 49/100

Q2 2021 Cellectis SA Earnings Call Transcript

Aug 06, 2021 / 12:00PM GMT
Release Date Price: €11.6 (+5.45%)
Operator

Greetings. Welcome to the Cellectis Second Quarter 2021 Earnings Call. (Operator Instructions). Please note that this conference is being recorded.

At this time, I'll now turn the conference over to Eric Dutang, Chief Financial Officer. Eric, you may now begin.

Eric Dutang
Cellectis S.A. - CFO

Thank you, and welcome, everyone, to Cellectis Second Quarter 2021 Corporate Update and Financial Results Conference Call. Joining me on the call today with prepared remarks is Dr. Andre Choulika, our Chief Executive Officer. Dr. Carrie Brownstein, our Chief Medical Officer; and Steve Doares, our Senior Vice President of U.S. Manufacturing, will be joining for the Q&A.

Yesterday evening, Cellectis filed its interim report and issued a press release reporting our financial results for the second quarter and 6-month period ending June 30, 2021. The report and press release are available on our website at cellectis.com.

As a reminder, we will make forward-looking statements regarding Cellectis' financial outlook in addition to its

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot